CA4 and ovarian carcinoma: Niu et al. replaced the double bond of CA-4 with a benzosuberene (highlighted in blue, Figure 8) ring structure to yield compounds 50 and 51 (Figure 8), with an IC50 of 6.9 nM in the ovarian cancer cell line SK-OV-3.